Large-gauge core needle biopsy of the breast

Handel E. Reynolds, Valerie Jackson, Florence M. Gin, Colleen M. Madden, Donald Hawes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Large-gauge core needle biopsy (LGCNB) of the breast is gaining acceptance as a viable alternative to surgical excision. The procedure can be performed efficiently using ultrasound or stereotactic guidance. We report our experience with 137 LGCNB performed over a 40-month period. One hundred thirty-seven lesions in 125 patients were subjected to LGCNB. Fifty-nine procedures were performed using stereotactic guidance and 78 using ultrasound guidance. Stereotactic procedures utilized a prone table and ultrasound procedures used a freehand technique. All biopsies were performed with a 14-gauge core needle attached to an automated biopsy device. There were 53 malignant and 84 benign diagnoses in this group of 137 LGCNB. Surgical correlation is available in 46 of the 53 malignant cases. There were no false positives, though one lesion was missed at the initial surgical excision but retrieved at reexcision. Of the 84 benign cases, there has been surgical (n = 10) or mammographic follow-up (n = 32) in 42. The mean duration of mammographic follow-up is 13 months (range: 5-36 months). There was one false negative LGCNB. The sensitivity, specificity, positive predictive value, and negative predictive value in this series are 98%, 100%, 100% and 96%, respectively. LGCNB has a high degree of accuracy and is well accepted by patients. There are some persistent difficulties with the technique, such as ensuring compliance with follow-up recommendations among patients with benign results and excluding invasive carcinoma.

Original languageEnglish
Pages (from-to)370-373
Number of pages4
JournalBreast Journal
Volume2
Issue number6
StatePublished - 1996

Fingerprint

Large-Core Needle Biopsy
Breast
Biopsy
Needles
Carcinoma
Sensitivity and Specificity
Equipment and Supplies

Keywords

  • Breast
  • Needle biopsy
  • Stereotactic biopsy

ASJC Scopus subject areas

  • Internal Medicine
  • Oncology

Cite this

Reynolds, H. E., Jackson, V., Gin, F. M., Madden, C. M., & Hawes, D. (1996). Large-gauge core needle biopsy of the breast. Breast Journal, 2(6), 370-373.

Large-gauge core needle biopsy of the breast. / Reynolds, Handel E.; Jackson, Valerie; Gin, Florence M.; Madden, Colleen M.; Hawes, Donald.

In: Breast Journal, Vol. 2, No. 6, 1996, p. 370-373.

Research output: Contribution to journalArticle

Reynolds, HE, Jackson, V, Gin, FM, Madden, CM & Hawes, D 1996, 'Large-gauge core needle biopsy of the breast', Breast Journal, vol. 2, no. 6, pp. 370-373.
Reynolds HE, Jackson V, Gin FM, Madden CM, Hawes D. Large-gauge core needle biopsy of the breast. Breast Journal. 1996;2(6):370-373.
Reynolds, Handel E. ; Jackson, Valerie ; Gin, Florence M. ; Madden, Colleen M. ; Hawes, Donald. / Large-gauge core needle biopsy of the breast. In: Breast Journal. 1996 ; Vol. 2, No. 6. pp. 370-373.
@article{9909d809652449cf87ded40321617e8d,
title = "Large-gauge core needle biopsy of the breast",
abstract = "Large-gauge core needle biopsy (LGCNB) of the breast is gaining acceptance as a viable alternative to surgical excision. The procedure can be performed efficiently using ultrasound or stereotactic guidance. We report our experience with 137 LGCNB performed over a 40-month period. One hundred thirty-seven lesions in 125 patients were subjected to LGCNB. Fifty-nine procedures were performed using stereotactic guidance and 78 using ultrasound guidance. Stereotactic procedures utilized a prone table and ultrasound procedures used a freehand technique. All biopsies were performed with a 14-gauge core needle attached to an automated biopsy device. There were 53 malignant and 84 benign diagnoses in this group of 137 LGCNB. Surgical correlation is available in 46 of the 53 malignant cases. There were no false positives, though one lesion was missed at the initial surgical excision but retrieved at reexcision. Of the 84 benign cases, there has been surgical (n = 10) or mammographic follow-up (n = 32) in 42. The mean duration of mammographic follow-up is 13 months (range: 5-36 months). There was one false negative LGCNB. The sensitivity, specificity, positive predictive value, and negative predictive value in this series are 98{\%}, 100{\%}, 100{\%} and 96{\%}, respectively. LGCNB has a high degree of accuracy and is well accepted by patients. There are some persistent difficulties with the technique, such as ensuring compliance with follow-up recommendations among patients with benign results and excluding invasive carcinoma.",
keywords = "Breast, Needle biopsy, Stereotactic biopsy",
author = "Reynolds, {Handel E.} and Valerie Jackson and Gin, {Florence M.} and Madden, {Colleen M.} and Donald Hawes",
year = "1996",
language = "English",
volume = "2",
pages = "370--373",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Large-gauge core needle biopsy of the breast

AU - Reynolds, Handel E.

AU - Jackson, Valerie

AU - Gin, Florence M.

AU - Madden, Colleen M.

AU - Hawes, Donald

PY - 1996

Y1 - 1996

N2 - Large-gauge core needle biopsy (LGCNB) of the breast is gaining acceptance as a viable alternative to surgical excision. The procedure can be performed efficiently using ultrasound or stereotactic guidance. We report our experience with 137 LGCNB performed over a 40-month period. One hundred thirty-seven lesions in 125 patients were subjected to LGCNB. Fifty-nine procedures were performed using stereotactic guidance and 78 using ultrasound guidance. Stereotactic procedures utilized a prone table and ultrasound procedures used a freehand technique. All biopsies were performed with a 14-gauge core needle attached to an automated biopsy device. There were 53 malignant and 84 benign diagnoses in this group of 137 LGCNB. Surgical correlation is available in 46 of the 53 malignant cases. There were no false positives, though one lesion was missed at the initial surgical excision but retrieved at reexcision. Of the 84 benign cases, there has been surgical (n = 10) or mammographic follow-up (n = 32) in 42. The mean duration of mammographic follow-up is 13 months (range: 5-36 months). There was one false negative LGCNB. The sensitivity, specificity, positive predictive value, and negative predictive value in this series are 98%, 100%, 100% and 96%, respectively. LGCNB has a high degree of accuracy and is well accepted by patients. There are some persistent difficulties with the technique, such as ensuring compliance with follow-up recommendations among patients with benign results and excluding invasive carcinoma.

AB - Large-gauge core needle biopsy (LGCNB) of the breast is gaining acceptance as a viable alternative to surgical excision. The procedure can be performed efficiently using ultrasound or stereotactic guidance. We report our experience with 137 LGCNB performed over a 40-month period. One hundred thirty-seven lesions in 125 patients were subjected to LGCNB. Fifty-nine procedures were performed using stereotactic guidance and 78 using ultrasound guidance. Stereotactic procedures utilized a prone table and ultrasound procedures used a freehand technique. All biopsies were performed with a 14-gauge core needle attached to an automated biopsy device. There were 53 malignant and 84 benign diagnoses in this group of 137 LGCNB. Surgical correlation is available in 46 of the 53 malignant cases. There were no false positives, though one lesion was missed at the initial surgical excision but retrieved at reexcision. Of the 84 benign cases, there has been surgical (n = 10) or mammographic follow-up (n = 32) in 42. The mean duration of mammographic follow-up is 13 months (range: 5-36 months). There was one false negative LGCNB. The sensitivity, specificity, positive predictive value, and negative predictive value in this series are 98%, 100%, 100% and 96%, respectively. LGCNB has a high degree of accuracy and is well accepted by patients. There are some persistent difficulties with the technique, such as ensuring compliance with follow-up recommendations among patients with benign results and excluding invasive carcinoma.

KW - Breast

KW - Needle biopsy

KW - Stereotactic biopsy

UR - http://www.scopus.com/inward/record.url?scp=0005422108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0005422108&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0005422108

VL - 2

SP - 370

EP - 373

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 6

ER -